Sigilon Therapeutics is a biotechnology company developing immunotherapies for the treatment of chronic diseases that is headquartered in Cambridge, Massachusetts and was founded in 2015 by Daniel Anderson, Robert Langer, Jose Oberholzher, Arturo Vegas, and Omid Veiseh.
The company looks to engineer human cells that are capable of restoring to a normal physiology after a range of diseases, and doing so without generating fibrosis, or immune rejection. They operate in fields of biotechnology, hemophilia, diabetes, lysosomal storage disorders, bio-compatible materials, and chronic disease solutions.
Sigilon Therapeutics has the goal of creating what they refer to as Shielded Living Therapeutics, which are engineered cells that provide a functional cure for chronic diseases. They have completed trials of their therapeutics in animals, and predict that should they succeed in human cases, these solutions will help generate the natural biomolecules a patient requires to maintain therapeutic protein replacement over long-term periods.
Lilly and Sigilon Therapeutics Announce Strategic Collaboration to Develop Encapsulated Cell Therapies for the Treatment of Type 1 Diabetes
Eli Lilly and Company
Sigilon Therapeutics and MIT Announce Research Collaboration to Advance Programmable Living Therapeutics for Serious Chronic Diseases
Sigilon Therapeutics Expands Intellectual Property Portfolio with New Patent Issued
With $23M, Flagship-Backed Sigilon Protects Protein-Producing Cells
Documentaries, videos and podcasts
October 18, 2018
- Cluster: BiotechnologyA cluster of topics related to biotechnology.
- Cluster: Stem cell technologyTechnology used for isolating, generating, growing and controlling the differentiation of stem cells into specialized cells and the application of stem cell technology for medical and non-medical purposes such as producing meat through cellular agriculture.
- BiotechnologyBiotechnology can refer to the application of science and technology to living organisms or the use of living organisms, their parts, products or models thereof to solve a problem, produce knowledge or produce goods and services. Biotechnology may involve the alteration of living or non-living materials.
- Stem cellStem cells are self-renewing cells that have the potential to become multiple different cell types in the body. Stem cells are found in developing embryos. Adult stem cells maintain and repair tissues throughout life. Induced pluripotent stem cells are a type of stem cell derived from adult cells that are reprogrammed in the lab.